STOCK TITAN

uniQure (NASDAQ: QURE) posts updated corporate presentation for investors

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

uniQure N.V. filed a Form 8-K to share that it has updated its corporate presentation for investors and other stakeholders. The company is providing the new presentation as Exhibit 99.1 under a Regulation FD disclosure, meaning it is being broadly shared to keep the market informed. The presentation is also available on uniQure’s investor relations website, although the website itself and its contents are not part of this report. The company states that the information in this item and Exhibit 99.1 is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and will only be incorporated into other securities filings if specifically referenced.

Positive

  • None.

Negative

  • None.
00-00000000001590560false00015905602026-01-132026-01-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 13, 2026

uniQure N.V.

(Exact Name of Registrant as Specified in Charter)

The Netherlands

  ​ ​ ​

001-36294

  ​ ​ ​

N/A

(State or Other
Jurisdiction of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

Paasheuvelweg 25a,
1105 BP Amsterdam, The Netherlands

  ​ ​ ​

N/A

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s telephone number, including area code: +31-20-240-6000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:

  ​ ​ ​

Trading Symbol(s)

  ​ ​

Name of each exchange on which registered:

Ordinary Shares, par value €0.05 per share

 

QURE

 

The Nasdaq Stock Market LLC
The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 7.01                        Regulation FD Disclosure.

uniQure N.V. (the “Company”) updated its corporate presentation. A copy of the presentation is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The presentation will also be available online at https://www.uniqure.com/investors-media/events-presentations; however, the Company’s website and any information contained on the website are not incorporated herein.

The information provided in this Item 7.01, including the accompanying Exhibit 99.1, shall be deemed “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall it be incorporated by reference in any filing made by the Company pursuant to the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of the general incorporation language of such filing, except to the extent that such filing incorporates by reference any or all of such information by express reference.

Item 9.01                        Financial Statements and Exhibits.

(d)            Exhibits.

Exhibit No.

  ​ ​

Description

99.1

 

Corporate Presentation issued by uniQure N.V.

104

 

Cover Page Interactive Data File (embedded with the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ​ ​ ​

UNIQURE N.V.

 

 

 

 

 

Date: January 13, 2026

By:

/s/ Jeannette Potts

 

 

JEANNETTE POTTS

 

 

Chief Legal and Compliance Officer

FAQ

What did uniQure (QURE) disclose in this Form 8-K?

uniQure disclosed that it has updated its corporate presentation and is furnishing the new presentation as Exhibit 99.1 under a Regulation FD disclosure.

What is Exhibit 99.1 in uniQure’s (QURE) latest 8-K?

Exhibit 99.1 is the updated corporate presentation issued by uniQure N.V., which accompanies the Form 8-K as an investor information exhibit.

Is the updated uniQure (QURE) presentation considered filed with the SEC?

No. The company states that the information in Item 7.01 and Exhibit 99.1 is deemed furnished, not filed, so it is not subject to Section 18 liability of the Exchange Act.

Can the uniQure (QURE) corporate presentation be incorporated into other SEC filings?

Yes, but only if another securities filing by uniQure expressly incorporates all or part of the information in Item 7.01 or Exhibit 99.1 by reference.

Where can investors access the updated uniQure (QURE) corporate presentation?

The updated presentation is furnished as Exhibit 99.1 to the Form 8-K and is also available on uniQure’s investor and media events and presentations page.

Does this uniQure (QURE) Form 8-K report new financial results?

No. The Form 8-K focuses on providing an updated corporate presentation and does not describe new financial statements or earnings data.

Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

1.37B
58.43M
6.08%
96.92%
16.51%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM